Rocket Pharmaceuticals, Inc. (RCKT)

NASDAQ

$2.24

$-0.07

(-3.26%)

Regular Market

Rocket Pharmaceuticals, Inc. (RCKT) Live Price Chart

Last updated: ⁦2026-10-14 15:44:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Rocket Pharmaceuticals, Inc. (RCKT) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.24, with a market capitalisation of $272.24M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.23 to $5.45. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$272.24M
Open	$2.26
Day's High	$67.48
Day's Low	$2.19
Previous Close	$2.30
Volume	657.11K
Average Volume	1.75M
P/E Ratio	--
52-Week High	$5.45
52-Week Low	$2.23
Dividend Yield	--
Earnings Date	--

Rocket Pharmaceuticals, Inc. (RCKT) Stock Price Today

Rocket Pharmaceuticals, Inc. (RCKT) is currently trading at $2.24 as of 2026-10-14 15:43:00, down 2.83% ($0.06) from the previous close of $2.30

During today's regular trading session, RCKT has traded between $2.19 and $67.48, with a trading volume of 657.11K shares. The current price is near the lower end of today's range.

Rocket Pharmaceuticals, Inc. (RCKT) 7-Day Stock Price Change

Over the past seven days, Rocket Pharmaceuticals, Inc. (RCKT) moved from $2.61 to $2.24, representing a decline of 14.37% ($0.38).

The stock traded between $2.23 and $2.78 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 2.75 million shares, up versus the previous seven-day period, indicating higher trading activity.

RCKT 52-Week Price Position

Position in Range: 0.3%

52W Low$2.23

52W High$5.45

RCKT is currently trading at $2.24, placing it 0.3% of the way from its 52-week low of $2.23 to its 52-week high of $5.45. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Rocket Pharmaceuticals, Inc. (RCKT)?

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Rocket Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	202
Exchange	NASDAQ
Company Website	https://www.rocketpharma.com

How to Buy Rocket Pharmaceuticals, Inc. (RCKT) Stock on MEXC

Eligible investors can buy real shares of Rocket Pharmaceuticals, Inc. (RCKT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RCKT and Place Your Order

Open the RealStocks trading page and search for RCKT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Rocket Pharmaceuticals, Inc. (RCKT) stock price today?

Rocket Pharmaceuticals, Inc. (RCKT) is currently trading at $ 2.24, down 2.83% ($0.06) from the previous close of $ 2.30. Intraday prices update in real time during regular trading hours.

2.Is RCKT stock going up or down today?

As of 2026-10-14 15:43:00, RCKT is trading at $ 2.24, down 2.83% ($0.06) from its previous close of $ 2.30. The stock has traded between $ 2.19 and $ 67.48 during today’s regular session. Past price movements do not guarantee future results.

3.What is RCKT pre-market price?

As of 2026-10-14 15:43:00, RCKT is trading at $ 2.29 in pre-market trading, down 0.39% ($0.01) from the previous close of $ 2.30. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RCKT after-hours price?

As of 2026-10-14 15:43:00, RCKT is trading at $ 2.32 in after-hours trading, up 0.78% ($0.02) from the regular-session close of $ 2.30. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RCKT stock trading now?

RCKT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RCKT sit relative to its 52-week high and low?

Over the past 52 weeks, RCKT has traded between a low of $ 2.23 and a high of $ 5.45. At $ 2.24, the stock is positioned 0.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Rocket Pharmaceuticals, Inc. in?

Rocket Pharmaceuticals, Inc. (RCKT) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Rocket Pharmaceuticals, Inc.'s market capitalisation and where is it listed?

Rocket Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 272.24M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RCKT valued in terms of P/E ratio and EPS?

RCKT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.16. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Rocket Pharmaceuticals, Inc. pay a dividend?

Rocket Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.